Celleron Therapeutics
Highly experienced management team
br>
Professor Nick La Thangue MA BSc MSc PhD FRSE FMedSci (Founding Director)
Nick has extensive commercial experience derived from the biotechnology sector of M&A, IPO and corporate financing. Currently he holds
the Chair of Cancer Biology at the University of Oxford and is a Fellow at Linacre College.
Professor David Kerr CBE MA MD DSc FRCP (Glas & Lon) FRCGP (Hon) FMedSci (Founding Director)
David has an international reputation for treatment of and research into colorectal cancer. He holds the Chair of Cancer Therapeutics at
Oxford University.